Brand Intelligence Graphcompany
Company Overview
About ResMed
ResMed Inc. is the global leader in cloud-connected medical devices and software for diagnosing and treating sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions in out-of-hospital settings. Founded in Sydney, Australia in 1989, the company designs and manufactures CPAP (continuous positive airway pressure) machines, masks, ventilators, and related accessories used by patients with obstructive sleep apnea — a condition affecting approximately 1 billion people globally that is chronically under-diagnosed and under-treated.
Business Model & Competitive Advantage
ResMed reported approximately $4.7 billion in revenue in FY2024, with its Devices segment (CPAP machines, ventilators) and Masks & Accessories segment contributing roughly equally. ResMed has over 10 million cloud-connected devices globally, streaming anonymized health data through the AirView platform that allows physicians and home medical equipment providers to monitor patient compliance and adjust therapy remotely. This data advantage — the largest real-world sleep apnea dataset — enables continuous product improvement and supports outcomes-based contracting with payers.
Competitive Landscape 2025–2026
The GLP-1 drug phenomenon (Ozempic, Wegovy) briefly pressured ResMed's stock as investors worried weight loss drugs would reduce CPAP demand by addressing obesity-driven sleep apnea. ResMed's analysis of its own data showed existing CPAP users are not abandoning therapy, and GLP-1 uptake may actually increase sleep apnea diagnosis rates by drawing patients to physicians who discover the condition. The software segment (Brightree for HME billing, MatrixCare for long-term care) adds SaaS diversification and is growing at higher rates than devices.
Recent Activity
View all →Key Differentiators
Market Leader
ResMed is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $4.7B in revenue, ResMed operates at enterprise scale with proven market validation.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Compare ResMed with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from ResMed? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim ResMed Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention ResMed vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →